Acutus Medical, Inc. AFIB
0.00 USD 0.00 (+0.00%)
Regular-session close
0.0005 Day range 0.0005
0.0001 52-week range 0.014
- YTD
- -50.00%
- 1 year
- -80.00%
News
defenseworld.net Analyzing West Pharmaceutical Services (NYSE:WST) and Acutus Medical (NASDAQ:AFIB) West Pharmaceutical Services (NYSE: WST - Get Free Report) and Acutus Medical (NASDAQ: AFIB - Get Free Report) are both healthcare companies, but which is the superior business? We will contrast the…
defenseworld.net Reviewing T2 Biosystems (NASDAQ:TTOO) & Acutus Medical (NASDAQ:AFIB) Risk and Volatility Acutus Medical has a beta of -1.28, meaning that its stock price is 228% less volatile than the S&P 500. Comparatively, T2 Biosystems has a beta of 0.88, meaning that its stock…
defenseworld.net Comparing Carmell (NASDAQ:CTCX) and Acutus Medical (NASDAQ:AFIB) Risk and Volatility Acutus Medical has a beta of -1.32, meaning that its share price is 232% less volatile than the S&P 500. Comparatively, Carmell has a beta of 0.51, meaning that its share price is…
defenseworld.net Acutus Medical (NASDAQ:AFIB) versus Assure (NASDAQ:IONM) Head to Head Survey Institutional and Insider Ownership 56.9% of Acutus Medical shares are owned by institutional investors. Comparatively, 3.3% of Assure shares are owned by institutional investors. 5.2% of Acutus…
defenseworld.net Financial Analysis: SANUWAVE Health (OTCMKTS:SNWV) vs. Acutus Medical (NASDAQ:AFIB) Profitability This table compares SANUWAVE Health and Acutus Medical's net margins, return on equity and return on assets. Net Margins Return on Equity Return on Assets SANUWAVE Health -1.33% -23.83%…
globenewswire.com Acutus Medical Reports Full Year 2024 Financial Results CARLSBAD, Calif., March 24, 2025 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (OTC: AFIB) today reported results for the full year of 2024.
globenewswire.com Acutus Medical Announces Operational Downsizing CARLSBAD, Calif., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), today announced a realignment of resources and operational downsizing.
globenewswire.com Acutus Medical Reports Third Quarter and Year-To-Date 2024 Financial Results CARLSBAD, Calif., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (OTC: AFIB) today reported results for the third quarter and year-to-date of 2024.
globenewswire.com Acutus Medical Reports Second Quarter and Year-To-Date 2024 Financial Results CARLSBAD, Calif., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (OTC: AFIB) today reported results for the second quarter and year-to-date of 2024.
globenewswire.com Acutus Medical Reports First Quarter 2024 Financial Results CARLSBAD, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (OTC: AFIB) today reported results for the first quarter of 2024.
investorplace.com Why Is Acutus Medical (AFIB) Stock Down 41% Today? Acutus Medical (NASDAQ: AFIB ) stock is falling hard on Monday as investors prepare for the arrhythmias tool development company's delisting later this week. AFIB stock is being delisted due to its…
globenewswire.com Acutus Medical Reports Fourth Quarter and Full Year 2023 Financial Results CARLSBAD, Calif., April 01, 2024 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB) today reported results for the fourth quarter and full year ended December 31,2023.
benzinga.com Top 4 Health Care Stocks That Could Blast Off This Quarter - Acutus Medical (NASDAQ:AFIB), Becton Dickinson (NYSE:BDX) The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
globenewswire.com Acutus Medical to Cancel Third Quarter 2023 Conference Call CARLSBAD, Calif., Nov. 10, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), today announced that, following the Company's announcement of its strategic…
globenewswire.com Acutus Medical Reports Third Quarter 2023 Financial Results CARLSBAD, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB) today reported results for the third quarter of 2023.
globenewswire.com Acutus Medical Announces Strategic Realignment of Resources and Corporate Restructuring CARLSBAD, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), today announced a realignment of resources and corporate restructuring.
globenewswire.com Acutus Medical to Announce Third Quarter 2023 Financial Results CARLSBAD, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and…
globenewswire.com Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) CARLSBAD, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias…
globenewswire.com Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) CARLSBAD, Calif., Oct. 02, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias…
